Deferred Tax Assets, Net of Valuation Allowance of Sonoma Pharmaceuticals, Inc. from 31 Mar 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Mar 2012 to 31 Mar 2025.
  • Sonoma Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Mar 2025 was $691,000, a 47% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Sonoma Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $691,000 -$607,000 -47% 31 Mar 2025 10-K 17 Jun 2025 2025 FY
Q1 2024 $1,298,000 +$171,000 +15% 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q1 2023 $1,127,000 -$42,000 -3.6% 31 Mar 2023 10-K 17 Jun 2024 2024 FY
Q1 2022 $1,169,000 +$905,000 +343% 31 Mar 2022 10-K 21 Jun 2023 2023 FY
Q1 2021 $264,000 -$103,000 -28% 31 Mar 2021 10-K 13 Jul 2022 2022 FY
Q1 2020 $367,000 +$367,000 31 Mar 2020 10-K 14 Jul 2021 2021 FY
Q1 2019 $0 $0 31 Mar 2019 10-K 10 Jul 2020 2020 FY
Q1 2018 $0 $0 31 Mar 2018 10-K 01 Jul 2019 2019 FY
Q1 2017 $0 $0 31 Mar 2017 10-K 26 Jun 2018 2018 FY
Q1 2016 $0 $0 31 Mar 2016 10-K 28 Jun 2017 2017 FY
Q1 2015 $0 $0 31 Mar 2015 10-K 21 Jun 2016 2016 FY
Q1 2014 $0 $0 31 Mar 2014 10-K 16 Jun 2015 2015 FY
Q1 2013 $0 $0 31 Mar 2013 10-K 30 Jun 2014 2014 FY
Q1 2012 $0 31 Mar 2012 10-K 25 Jun 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.